Epidermal Growth Factor (EGF) and Botulinum Toxin (BTX); Can Paralysis Be A Bless?
, 2016 Botulinum toxin (BTX) commercially known as Botox is produced by Clostridium Botulinum, it has many different subtypes. It is a relatively safe agent with very few local and systemic adverse effects, and is currently used in a wide range of medical ...
Bakr, Mahmoud M +2 more
core
Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review
DEN Open, Volume 7, Issue 1, April 2027.ABSTRACT Objectives To review the evidence base, evolution, outcomes, adverse events (AEs), and management for third‐space endoscopy (TSE) procedures for management of benign motility disorders. Methods This review examines TSE procedures for motility disorders, reviewing the current available techniques, success, outcomes, and long‐term outcomes from ...
Sanjana Bhagwat, Amol Bapaye
wiley +1 more source
Randomized, double-blind pilot study on botulinum toxin type A in the treatment of axillary hidradenitis suppurativa. [PDF]
An Bras DermatolKim JSTW +6 more
europepmc +1 more source
Report of Adverse Events Associated With Cutaneous Procedures: Update From the CAPER Registry
Lasers in Surgery and Medicine, Volume 58, Issue 9, Page 796-801, November 2026.ABSTRACT Objectives To systematically evaluate submissions to the CAPER database by analyzing procedural context, characteristics of reported adverse events (AEs), and provider involvement in order to identify patterns with potential implications for patient safety.
Sabrina S. Smith +9 more
wiley +1 more source
Botulinum Toxin Therapy for Diseases in the Oral and Maxillofacial Regions: Current Evidence and Future Perspectives. [PDF]
Toxins (Basel)Yoshida K.
europepmc +1 more source
Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 4, Page 748-760, October 2026.Abstract Objective Pediatric aerodigestive and upper gastrointestinal (UGI) motility disorders are common and may be associated with compromised nutritional status and decreased quality of life. Traditional dietary recommendations for aerodigestive and UGI motility disorders have been rudimentary and largely based upon experience and common sense ...
Khalil El‐Chammas +8 more
wiley +1 more source
Botulinum Toxin: Preclinical and Clinical Aspects. [PDF]
J Neural Transm (Vienna)Dressler D, Frevert J.
europepmc +1 more source
Management of Absent Upper Esophageal Sphincter Opening After Neurological Injury
The Laryngoscope, Volume 136, Issue 10, Page 4383-4391, October 2026.This study evaluated the effects of swallowing therapy and cricopharyngeus (CP) muscle surgery on upper esophageal sphincter (UES) opening, oral intake, and airway protection in patients with absent UES opening following neurological injury. CP‐targeted surgeries were associated with improved bolus passage and oral intake, but persistent aspiration ...
Radhika Rawat +7 more
wiley +1 more source
Monitoring complications of botulinum toxin in community practice: A pharmacological study. [PDF]
BioinformationRemesh A +7 more
europepmc +1 more source
Cytoskeletal Dynamics in Cancer: From Pathogenesis to Treatment
MedComm, Volume 7, Issue 10, October 2026.This review systematically addresses the fundamental roles of the cytoskeleton (actin filaments, microtubules, and intermediate filaments) in cancer progression. We focus on how cytoskeletal dynamics regulate tumor proliferation, metastasis, and programmed cell death, while also modulating the immune microenvironment. Understanding these mechanisms may
Jie Chen +9 more
wiley +1 more source